- Applied DNA Sciences ( APDN ) +116% .
- Poseida Therapeutics ( PSTX ) +81% .
- Ping Identity Holding ( PING ) +60% Non-GAAP EPS of -$0.34 misses by $0.22, revenue of $72.03M misses by $1.27M.
- Alnylam Pharmaceuticals ( ALNY ) +47% as Phase 3 trial for ATTR amyloidosis therapy meet main goal.
- MediaCo Holding ( MDIA ) +35% .
- AMTD IDEA ( AMTD ) +25% .
- SemiLEDs ( LEDS ) +22% .
- Ocean Power Technologies ( OPTT ) +22% .
- Connexa Sports Technologies ( CNXA ) +22% .
- Aethlon Medical ( AEMD ) +24% .
- Rigel Pharmaceuticals ( RIGL ) +17% Q2 - Results - Earnings Call Presentation.
- Precipio ( PRPO ) +16% .
- Intellia Therapeutics ( NTLA ) +15% .
- China SXT Pharmaceuticals ( SXTC ) +16% .
- Second Sight Medical Products ( EYES ) +14% .
- PayPal Holdings ( PYPL ) +13% announces stock selling by selling shareholder.
- Atlas Air Worldwide Holdings ( AAWW ) +12% likely to be acquired for $102.5/share by Apollo-led group.
- Arcutis Biotherapeutics ( ARQT ) +12% gains on pricing $150M sock offering.
- SoFi Technologies ( SOFI ) +11% CEO Anthony Noto on Q2 2022 Results - Earnings Call Transcript.
- Quoin Pharmaceuticals ( QNRX ) +9% .
- NeuroOne Medical Technologies ( NMTC ) +10% .
- Faraday Future Intelligent Electric ( FFIE ) +9% .
- Bionano Genomics ( BNGO ) +9% .
- Coherus BioSciences ( CHRS ) +8% on FDA nod for Roche Lucentis' interchangeable biosimilar Cimerli.
- Sierra Wireless ( SWIR ) +8% as Wedbush downgrades after Sierra Wireless deal.
For further details see:
BNGO, NTLA and OPTT are among pre market gainers